Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching
- PMID: 15688346
- DOI: 10.1002/eji.200425848
Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching
Abstract
Transforming growth factor (TGF)-beta1 directs class switch recombination (CSR) to IgG2b as well as to IgA. Smad3/4, Runx3 and p300 mediate TGF-beta1-induced germ-line (GL) alpha transcription leading to IgA expression. However, the molecular mechanisms by which TGF-beta1 induces IgG2b CSR are unknown. We used luciferase reporter plasmids to investigate how TGF-beta1 regulates the activity of the promoter for GL transcripts of IgG2b constant gene (GLgamma2b promoter). Similarly to the GLalpha promoter, overexpression of Smad3/4 and Runx3 enhances TGF-beta1-induced GLgamma2b promoter activity. Mutation analysis of the promoter identified likely Smad- and Runx3-binding sites. Also similar to the GLalpha promoter, overexpression of p300 enhances Smad3/4-mediated promoter activity, whereas E1A represses promoter activity. Since these regulation mechanisms underlying both GLalpha and GLgamma2b transcription are similar, we explored the possibility that TGF-beta1 induces IgA CSR via transitional IgG2b CSR. TGF-beta1 enhances the expression of both Ialpha-Cmu and Ialpha-Cgamma2b circle transcripts, indicative of direct (Smu-->Salpha) and sequential CSR (Smu-->Sgamma2b-->Salpha).
Similar articles
-
p300 cooperates with Smad3/4 and Runx3 in TGFbeta1-induced IgA isotype expression.Eur J Immunol. 2003 Dec;33(12):3386-92. doi: 10.1002/eji.200324061. Eur J Immunol. 2003. PMID: 14635047
-
Analyses of TGF-beta1-inducible Ig germ-line gamma2b promoter activity: involvement of Smads and NF-kappaB.Eur J Immunol. 2009 Apr;39(4):1157-66. doi: 10.1002/eji.200838732. Eur J Immunol. 2009. PMID: 19266485
-
Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes.Eur J Immunol. 2001 Jun;31(6):1706-15. doi: 10.1002/1521-4141(200106)31:6<1706::aid-immu1706>3.0.co;2-z. Eur J Immunol. 2001. PMID: 11385614
-
TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.Arch Oral Biol. 2004 Nov;49(11):911-8. doi: 10.1016/j.archoralbio.2004.05.005. Arch Oral Biol. 2004. PMID: 15353247
-
The regulation of IgA class switching.Nat Rev Immunol. 2008 Jun;8(6):421-34. doi: 10.1038/nri2322. Nat Rev Immunol. 2008. PMID: 18483500 Free PMC article. Review.
Cited by
-
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.Pharmaceuticals (Basel). 2024 Apr 20;17(4):533. doi: 10.3390/ph17040533. Pharmaceuticals (Basel). 2024. PMID: 38675493 Free PMC article. Review.
-
TGF-β signaling in health and disease.Cell. 2023 Sep 14;186(19):4007-4037. doi: 10.1016/j.cell.2023.07.036. Cell. 2023. PMID: 37714133 Free PMC article. Review.
-
Pathogen-associated T follicular helper cell plasticity is critical in anti-viral immunity.Sci China Life Sci. 2022 Jun;65(6):1075-1090. doi: 10.1007/s11427-021-2055-x. Epub 2022 Mar 2. Sci China Life Sci. 2022. PMID: 35258743
-
Targeting TGFβ signal transduction for cancer therapy.Signal Transduct Target Ther. 2021 Jan 8;6(1):8. doi: 10.1038/s41392-020-00436-9. Signal Transduct Target Ther. 2021. PMID: 33414388 Free PMC article. Review.
-
Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.J Clin Immunol. 2021 Jan;41(1):76-88. doi: 10.1007/s10875-020-00881-9. Epub 2020 Oct 14. J Clin Immunol. 2021. PMID: 33052516
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
